MASSMUTUAL TRUST CO FSB/ADV - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
MASSMUTUAL TRUST CO FSB/ADV ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2023$1,026
-4.6%
120.0%0.00%
Q3 2023$1,075
+5.2%
120.0%0.00%
Q2 2023$1,022
+2.9%
120.0%0.00%
Q1 2023$993
+99200.0%
120.0%0.00%
Q4 2022$1
-100.0%
12
-78.6%
0.00%
Q3 2021$4,000560.00%
Q2 2015$000.00%
Q2 2014$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q1 2014$9,777,000
-22.6%
3000.0%0.01%
-50.0%
Q4 2013$12,639,0003000.01%
Other shareholders
HAEMONETICS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders